Drug recalls

Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist…

SUN PHARMA /TARO · Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).

Class IIOngoingD-0848-2026
Status
Ongoing
City
Hawthorne
State
NY
Country
United States
Classification
Class II
Product type
Drugs
Event ID
99794
Recalling firm
SUN PHARMA /TARO
Address 1
3 Skyline Dr
Address 2
N/A
Postal code
10532-2174
Voluntary mandated
Voluntary: Firm initiated
Initial firm notification
Letter
Distribution pattern
Nationwide in the USA
Recall number
D-0848-2026
Product quantity
65,328 50g jars
Reason for recall
Failed Content Uniformity Specifications. Out of Specification for Assay during analysis at the 24- month long term stability station, at (25¿C,60%RH).
Recall initiation date
20260831
Center classification date
20260915
Report date
20260923
Code info
Lot # AD48154, Exp: 4/30/2027.
Product description

Lidocaine Ointment USP, 5%, Speermint Flavor, 50 g Jar, Rx only, Mfd. by: Taro Pharmaceuticals Inc., Brampton, Ontario, L6T1C, Canada, Dist By: Taro Pharmaceuticals U.S.A. Inc. Hawthorne NY 70532 NDC: 51672-3008-5

Harmonized identifiers (openFDA)
Application number
ANDA086724
Brand name
LIDOCAINE
Generic name
LIDOCAINE
Manufacturer name
Sun Pharmaceutical Industries, Inc.
Product NDC
51672-3008
Product type
HUMAN PRESCRIPTION DRUG
Route
TOPICAL
Substance name
LIDOCAINE
RxCUI
1543069
SPL ID
5353eb70-1eeb-5479-e063-6394a90a2e2b
SPL set ID
5eb2c62f-5352-41d7-bd66-c65b1988a9ab
Package NDC
51672-3008-5, 51672-3008-3
Is original packager
true
Nui
N0000175682, M0000897, N0000175426, N0000175976
Pharm class epc
Amide Local Anesthetic [EPC], Antiarrhythmic [EPC]
Pharm class cs
Amides [CS]
Pharm class pe
Local Anesthesia [PE]
UNII
98PI200987
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.